Yahoo Search Busca da Web

Entrar

Resultado da Busca

  1. www.inibio.eu › news › captaintcellsCaptain T Cell Secures Seed Financing Round Totaling € 8.5 ...

    Há 13 horas · Captain T Cell GmbH, a biotechnology company developing next-generation T cells against solid tumors, today announced the successful closing of a seed financing round totaling € 8.5 million. A syndicate of experienced life science investors including i&i Biotech Fund I SCSp, Brandenburg Kapital GmbH, and HIL-INVENT Ges.m.b.H participated in the round.

  2. www.wallstreet-online.de › nachricht › 18121063Multiple Abstracts Highlighting Vir Biotechnology’s Latest ...

    Há 13 horas · 22.05.2024 - Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that three abstracts highlighting new data from the Company’s chronic hepatitis delta and chronic hepatitis B programs have ...

  3. Vídeos

    Ver tudo

  4. www.stocktitan.net › news › VIRMultiple Abstracts Highlighting Vir Biotechnology’s Latest ...

    Há 13 horas · Vir Biotechnology, Inc. today announced that three abstracts highlighting new data from the Company’ s chronic hepatitis delta and chronic hepatitis B programs have been accepted for presentation at the annual meeting of the European Association for the Study of the Liver, EASL™ Congress 2024, taking place in Milan, Italy from June 5-8.

  5. www.starting-up.de › news › news-investmentsCaptain T Cell: 8,5 Mio. Euro für Berliner BioTech-Start-up

    23 de mai. de 2024 · share me! weiterleiten. Captain T Cell: 8,5 Mio. Euro für Berliner BioTech-Start-up. Captain T Cell – von einem Team von Immunonkologie-Experten gegründet – entwickelt TCR-T-Zellen mit erhöhter Wirksamkeit für solide Tumore, die mit bestehenden Therapien nicht behandelt werden können. Das Kapital aus der Seed-Finanzierungsrunde wird ...

  6. Imagens

    • Infographic: The Landscape of Plant Biotechnology in Europe – Valentin ...
    • Infographic: The Biggest Biotech Company in Each European Country
    • Biotechnology will take over Europe in September! – European Biotech Week
    • Biotech in Europe: A strong foundation for growth and innovation | McKinsey
    • Expanding into European Biotech | Deloitte US

    Ver tudo

  7. www.finanzen.at › nachrichten › aktienMarinomed Biotech-Aktie: Marinomed erleidet in Q1 ...

    Há 13 horas · Marinomed Biotech-Aktie: Marinomed erleidet in Q1 Umsatzeinbruch. Das börsennotierte Korneuburger Biotechnologie-Unternehmen Marinomed hat für das erste Quartal 2024 einen Umsatzrückgang vermeldet. Der Umsatz ging von 3,3 Mio. Euro auf 0,7 Mio. Euro zurück.

  8. www.standard-journal.com › ap › businessSixPeaks Bio AG Debuts With $110 Million in Funding ...

    Há 13 horas · BASEL, Switzerland-- (BUSINESS WIRE)--May 22, 2024--. SixPeaks Bio AG today emerged from stealth mode with a pipeline of therapies for healthy weight loss, including a potentially best-in-class dual-specific antibody targeting activin type IIA and B receptors. The company has secured $30 million in Series A financing led by founding investor ...

  9. www.4investors.de › nachrichten › boerseMarinomed Biotech legt Quartalszahlen vor - Liquidität im ...

    Há 13 horas · Marinomed Biotech meldet für das erste Quartal 2024 einen Umsatzrückgang von 3,3 Millionen Euro auf 0,7 Millionen Euro. Vor Zinsen und Steuern steigt das Minus von 1,4 Millionen Euro auf 1,9